MedPath

Coffee consumption and glucose tolerance in humans.

Recruiting
Conditions
Diabetes Mellitus type 2 (DM type II)
Registration Number
NL-OMON23240
Lead Sponsor
Vrije Universiteit (VU) Amsterdam, Institute for Health Sciences. The study will be executed at the Vrije Universiteit (VU) Medical Center, Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1. Apparently healthy males;
Acute effects of coffee and major coffee components on glucagon-like peptide 1 response and glucose tolerance in humans;

Exclusion Criteria

1. Women;

2. Smokers;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glucose and insulin concentrations in blood
Secondary Outcome Measures
NameTimeMethod
Glucagon-like peptide-1 concentrations and dipeptidyl peptidase IV activity in blood
© Copyright 2025. All Rights Reserved by MedPath